We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

67 hedge funds and large institutions have $504M invested in Loxo Oncology, Inc in 2016 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 16

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

0% more capital invested

Capital invested by funds: $502M → $504M (+$1.62M)

8% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 13

1% less funds holding

Funds holding: 6867 (-1)

Holders
67
Holders Change
-1
Holders Change %
-1.47%
% of All Funds
1.79%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
12
Increased
27
Reduced
16
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AC
1
Aisling Capital
New York
$104M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$80.6M +$278K +13,294 +0.5%
O
3
OrbiMed
New York
$59.5M
NMC
4
NEA Management Company
Maryland
$49M
RIM
5
RS Investment Management
California
$38.5M -$788K -37,660 -3%
EAM
6
Eventide Asset Management
Massachusetts
$20.2M +$3.91M +186,700 +34%
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$19.1M +$4.19M +200,000 +40%
Wellington Management Group
8
Wellington Management Group
Massachusetts
$13.5M +$10.3M +494,432 New
DCM
9
Driehaus Capital Management
Illinois
$9.05M -$462K -22,057 -6%
PC
10
PointState Capital
New York
$7.66M +$5.86M +280,000 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$7.58M +$519K +24,797 +10%
Axa
12
Axa
France
$7.41M -$91.7K -4,380 -2%
Capital World Investors
13
Capital World Investors
California
$7.16M +$5.48M +262,000 New
DM
14
Deerfield Management
New York
$6.86M
CC
15
Casdin Capital
New York
$6.83M -$31.4K -1,500 -0.6%
BFA
16
BlackRock Fund Advisors
California
$6.36M -$105K -5,033 -2%
PC
17
Paulson & Co
New York
$6.16M +$3M +143,162 +174%
EI
18
EAM Investors
California
$5.87M +$2.2M +105,004 +96%
AIC
19
AWM Investment Company
New York
$5.47M +$1.99M +95,000 +90%
EC
20
EcoR1 Capital
California
$4.11M +$3.15M +150,308 New
BIT
21
BlackRock Institutional Trust
California
$4.06M +$455K +21,737 +17%
BBA
22
Baker Bros. Advisors
New York
$3.77M
State Street
23
State Street
Massachusetts
$3.64M +$191K +9,142 +7%
Northern Trust
24
Northern Trust
Illinois
$2.51M +$49.1K +2,348 +3%
UBS AM
25
UBS AM
Illinois
$2.2M +$1.68M +80,344 New

LOXO Hedge Fund Activity: Q1 2016 in Review

67 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q1 2016, worth a combined $504M — up 0.32% from $502M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of LOXO and 12 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 27 added.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $10.3M. The largest seller was BVF Inc, cutting an estimated $13.3M.

  • 67 institutional investors held Loxo Oncology, Inc (LOXO) as of Q1 2016, down from 68 in Q4 2015.
  • Funds reported $504M of Loxo Oncology, Inc stock for Q1 2016, up 0.32% quarter-over-quarter.
  • 12 funds opened new Loxo Oncology, Inc positions in Q1 2016 and 13 closed out, a net change of -1 holder.
  • The largest Loxo Oncology, Inc buyer in Q1 2016 was Wellington Management Group, an estimated $10.3M added.
  • The largest Loxo Oncology, Inc seller in Q1 2016 was BVF Inc, an estimated $13.3M sold.

Based on aggregated 13F filings for Q1 2016.